Over the past 12 months, 3 insiders at Theravance Biopharma, Inc. filed 18 open-market SEC Form 4 transactions on TBPH: 0 purchases worth $0 and 18 sales worth $3.6M. Insiders have been net sellers over this period. The most recent filing was on Jul 7, 26.
| Date | Insider | Type | Shares | Price | Value |
|---|---|---|---|---|---|
| Jul 7, 26 | Eli Samaha | SELL | 5.6K | $17.17 | $96K |
| Jul 6, 26 | Eli Samaha | SELL | 1.4K | $17.04 | $24K |
| Jun 15, 26 | Rhonda FarnumSVP, COMM & MEDICAL AFFAIRS | SELL | 6.7K | $16.39 | $109K |
| Mar 16, 26 | Rhonda FarnumSVP, COMM & MEDICAL AFFAIRS | SELL | 15.5K | $14.00 | $217K |
| Dec 3, 25 | Rhonda FarnumSVP, COMM & MEDICAL AFFAIRS | SELL | 15.5K | $18.75 | $291K |
| Nov 26, 25 | Eran BroshyDirector | SELL | 15.5K | $20.00 | $310K |
| Nov 11, 25 | Eran BroshyDirector | SELL | 29.5K | $18.50 | $546K |
| Jul 14, 25 | Rhonda FarnumSVP, COMM & MEDICAL AFFAIRS | SELL | 5.3K | $11.39 | $61K |
| Jun 2, 25 | Rhonda FarnumSVP, COMM & MEDICAL AFFAIRS | SELL | 24.0K | $11.00 | $264K |
| Apr 21, 25 | Rhonda FarnumSVP, COMM & MEDICAL AFFAIRS | SELL | 4.0K | $9.00 | $36K |
| Jan 21, 25 | Rhonda FarnumSVP, COMM & MEDICAL AFFAIRS | SELL | 4.0K | $9.00 | $36K |
| Nov 11, 24 | Rhonda FarnumSVP, COMM & MEDICAL AFFAIRS | SELL | 4.0K | $9.00 | $36K |
| Aug 7, 24 | Eli SamahaTenPercentOwner | BUY | 999.8K | $7.80 | $7.8M |
| Jul 10, 24 | Rhonda FarnumSVP, COMM & MEDICAL AFFAIRS | SELL | 4.0K | $9.00 | $36K |
| May 1, 24 | Eli SamahaTenPercentOwner | BUY | 999.8K | $8.75 | $8.7M |
| Feb 22, 24 | Rhonda FarnumSVP, COMM & MEDICAL AFFAIRS | SELL | 1.3K | $8.71 | $11K |
| Nov 21, 23 | Rhonda FarnumSVP, COMM & MEDICAL AFFAIRS | SELL | 1.4K | $10.29 | $14K |
| Nov 14, 23 | Richard A GrahamSVP, RESEARCH & DEVELOPMENT | SELL | 2.5K | $10.22 | $25K |
| Oct 16, 23 | Richard A GrahamSVP, RESEARCH & DEVELOPMENT | SELL | 2.5K | $9.03 | $22K |
| Sep 14, 23 | Richard A GrahamSVP, RESEARCH & DEVELOPMENT | SELL | 2.5K | $9.89 | $25K |
| Aug 22, 23 | Rhonda FarnumSVP, COMM & MEDICAL AFFAIRS | SELL | 1.8K | $9.47 | $17K |
| Aug 11, 23 | Richard A GrahamSVP, RESEARCH & DEVELOPMENT | SELL | 2.3K | $9.99 | $23K |
| Jul 14, 23 | Richard A GrahamSVP, RESEARCH & DEVELOPMENT | SELL | 2.3K | $9.84 | $23K |
| Jun 14, 23 | Richard A GrahamSVP, RESEARCH & DEVELOPMENT | SELL | 2.3K | $10.69 | $25K |
| Jun 8, 23 | Rhonda FarnumSVP, COMM & MEDICAL AFFAIRS | SELL | 1.8K | $11.13 | $20K |
| May 15, 23 | Richard A GrahamSVP, RESEARCH & DEVELOPMENT | SELL | 2.3K | $11.26 | $26K |
| Apr 14, 23 | Richard A GrahamSVP, RESEARCH & DEVELOPMENT | SELL | 2.3K | $11.88 | $28K |
| Mar 14, 23 | Richard A GrahamSVP, RESEARCH & DEVELOPMENT | SELL | 2.3K | $10.32 | $24K |
| Mar 9, 23 | Rhonda FarnumSVP, COMM & MEDICAL AFFAIRS | SELL | 4.0K | $10.20 | $41K |
| Mar 6, 23 | Richard A GrahamSVP, RESEARCH & DEVELOPMENT | SELL | 2.3K | $10.05 | $23K |
| Dec 14, 22 | Rick E WinninghamCHIEF EXECUTIVE OFFICER | SELL | 50.0K | $11.19 | $560K |
| Dec 1, 22 | Richard A GrahamSVP, RESEARCH & DEVELOPMENT | SELL | 2.1K | $10.73 | $22K |
| Nov 18, 22 | Andrew A. HindmanSVP, CHIEF FINANCIAL OFFICER | SELL | 65.0K | $11.02 | $716K |
| Aug 16, 22 | Richard A GrahamSVP, DEVELOPMENT | SELL | 4.9K | $9.71 | $48K |
| Aug 9, 22 | Richard A GrahamSVP, DEVELOPMENT | SELL | 15.1K | $8.79 | $133K |
| May 23, 22 | Rhonda FarnumSVP, COMM & MEDICAL AFFAIRS | SELL | 1.1K | $8.93 | $10K |
| Feb 28, 22 | Rhonda FarnumSVP, COMM & MEDICAL AFFAIRS | SELL | 2.4K | $10.16 | $24K |
Over the past 12 months, insiders at Theravance Biopharma, Inc. filed 0 open-market purchases worth $0 and 18 sales worth $3.6M on TBPH, which makes them net sellers over the period. The most recent Form 4 was filed on Jul 7, 26.
The largest recent open-market TBPH insider purchase in our data was $8.7M by Eli Samaha, TenPercentOwner, filed on May 1, 24.
3 different insiders at Theravance Biopharma, Inc. filed open-market SEC Form 4 transactions on TBPH over the last 12 months.
InsiderTape plots every TBPH insider buy and sell directly on the price chart and flags new SEC Form 4 filings as they arrive, with cluster detection and buy/sell pressure. The data updates daily from SEC EDGAR.
InsiderTape plots every Theravance Biopharma, Inc. insider buy and sell on the price chart, with buy/sell pressure, cluster detection, and alerts the moment new Form 4s hit. Start a free 7-day trial, cancel anytime.
Does it work? In five years of data, insider clusters beat the Russell 2000 about 60% of the time and the CFO's buy was the sharpest signal of all. See the backtest →
START FREE TRIAL →